Clinical Trial

Arterial Stiffening as a Predictor for Diastolic Cardiac Dysfunction and HFpEF

Study acronym: ARTSPREDICTION
Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated May 9, 2024 (before its estimated January 2026 completion). Its status may not reflect the trial's current state.
Summary
Patients at risk for developing heart failure with preserved ejection fraction (HFpEF) will undergo a structured clinical assessment, transthoracic echocardiography and pulse-wave analysis to investigate the association of arterial stiffening and the development of cardiac diastolic dysfuntion and HFpEF.
Protocol Amendment History 4 amendments
This ClinicalTrials.gov record has been amended 4 times since 2024-01-05; most recent amendment 2024-05-08.
Status change: Not Yet Recruiting → Recruiting 2024-02-28
Trial Details
NCT Number NCT06208007
Lead Sponsor University Medical Center Goettingen
Conditions Heart Failure With Preserved Ejection Fraction, Cardiovascular Morbidity
Enrollment 150 participants
Start Date 2024-02-23
Primary Completion 2026-01 (estimated)
Study Completion 2028-01 (estimated)
Updated on ClinicalTrials.gov 2024-05-09